: The acquisition of assets from bankrupt rival Rite Aid has added roughly 9 million new patients to its pharmacy network. Potential Risks to Consider
Some analysts project a 12-month price target averaging , implying over 20% upside.
: CVS offers a 3.4% dividend yield , which is more than double the S&P 500 average.
: Ongoing antitrust scrutiny of pharmacy benefit managers (PBMs) and potential changes to Medicare Advantage rates remain key risks for the 2027 fiscal year.
Management projects 2026 adjusted EPS between .
AI responses may include mistakes. For financial advice, consult a professional. Learn more Is CVS Health the Ultimate Value Stock to Buy Right Now?